Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT06976970
Active, not recruiting Observational

Diet Quality And Metabolic Syndrome In Adult Individuals: Evaluation Of Turkey Nutrition And Health Survey 2017

NCT06976970 · tracked via the Priya Life Science Turkey tracker
Sponsor
Elif Akbas
Phase
Observational
Started
2024-11-01
Last updated
2025-05-16

Condition(s) studied

Metabolic Syndrome

Study summary

This study investigates how the quality of a person's diet may be related to metabolic syndrome, which includes health issues such as high blood pressure, high blood sugar, and abdominal obesity. The research uses existing data from the 2017 Turkey Nutrition and Health Survey, focusing on adults aged 19 and over. The study does not involve any medical treatments or new data collection. It aims to support public health efforts by identifying links between eating patterns and metabolic health in the Turkish population.

Eligibility

Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * 19 years and older * Participated in the 2017 Turkey Nutrition and Health Survey (TNHS) Exclusion Criteria: * Pregnant or lactating women, individuals with cancer, psychiatric or neurological disorders, those on specific therapeutic diets, individuals with missing key variables, and those with implausible energy intake levels (\<800 or \>4000 kcal/day for men, \<500 or \>3500 kcal/day for women).

Primary outcome measure(s)

  • Metabolic Syndrome (MetS) — Day 1
    The primary outcome is the presence or absence of metabolic syndrome, defined according to the Joint Interim Statement criteria (2009). Participants are classified as having MetS if they meet at least three of the following five components: abdominal obesity, elevated blood pressure, elevated fasting glucose, elevated triglycerides, and reduced HDL cholesterol.
  • HEI-2015 Score — Day 1
    Diet quality will be assessed using the Healthy Eating Index-2015 (HEI-2015).
  • Dietary Inflammatory Index (DII) — Day 1
    Diet quality will be assessed using the Dietary Inflammatory Index (DII).
  • Mediterranean Diet Score (MDS) — Day 1
    Diet quality will be assessed using the Mediterranean Diet Score (MDS).
  • DASH Score (Dietary Approaches to Stop Hypertension) — Day 1
    Diet quality will be assessed using the DASH (Dietary Approaches to Stop Hypertension) score.

Trial sites (1)

FacilityCityRegionStatus
Ondokuz Mayıs University Samsun Turkey (Türkiye)

Other trials for the same condition

CKM Syndrome Prevalence and Its Association With SCORE-2 and BRI Starting soon
Emotional Eating, Sleep Quality, Mental State and Metabolic Syndrome Recruiting
EFFECTS OF OLEUROPEIN ON BLOOD PARAMETERS AND INFLAMMATORY MARKERS IN ADULTS WITH METABOLIC SYNDROME Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06976970 on ClinicalTrials.gov ↗ ← All trials in Turkey